Login / Signup

Bacteriophages suppress CRISPR-Cas immunity using RNA-based anti-CRISPRs.

Sarah Camara-WilpertDavid Mayo-MuñozJakob RusselRobert D FagerlundJonas Stenløkke MadsenPeter C FineranSøren Johannes SørensenRafael Pinilla-Redondo
Published in: Nature (2023)
Many bacteria use CRISPR-Cas systems to combat mobile genetic elements, such as bacteriophages and plasmids 1 . In turn, these invasive elements have evolved anti-CRISPR proteins to block host immunity 2,3 . Here we unveil a distinct type of CRISPR-Cas Inhibition strategy that is based on small non-coding RNA anti-CRISPRs (Racrs). Racrs mimic the repeats found in CRISPR arrays and are encoded in viral genomes as solitary repeat units 4 . We show that a prophage-encoded Racr strongly inhibits the type I-F CRISPR-Cas system by interacting specifically with Cas6f and Cas7f, resulting in the formation of an aberrant Cas subcomplex. We identified Racr candidates for almost all CRISPR-Cas types encoded by a diverse range of viruses and plasmids, often in the genetic context of other anti-CRISPR genes 5 . Functional testing of nine candidates spanning the two CRISPR-Cas classes confirmed their strong immune inhibitory function. Our results demonstrate that molecular mimicry of CRISPR repeats is a widespread anti-CRISPR strategy, which opens the door to potential biotechnological applications 6 .
Keyphrases
  • crispr cas
  • genome editing
  • genome wide
  • escherichia coli
  • copy number
  • gene expression
  • dna methylation
  • transcription factor